These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1519632)

  • 1. The evolution of antihypertensive therapy: current theoretical conditions and individualized treatment options.
    Weber MA
    Am J Med; 1992 Aug; 93(2A):1S-3S. PubMed ID: 1519632
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of the treatment of hypertension: what really matters in the 1990s?
    Hollenberg NK
    Am J Med; 1992 Aug; 93(2A):4S-10S. PubMed ID: 1519635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy: the future has already come.
    Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):2. PubMed ID: 20459512
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential improvements in antihypertensive drug treatment.
    Birkenhäger WH; de Leeuw PW
    Neth J Med; 1990 Aug; 37(1-2):49-52. PubMed ID: 2145520
    [No Abstract]   [Full Text] [Related]  

  • 6. The dual challenge of BP control.
    Fuster V; King A
    Nat Rev Cardiol; 2009 Dec; 6(12):729-30. PubMed ID: 19935679
    [No Abstract]   [Full Text] [Related]  

  • 7. Have long-term benefits of antihypertensive therapy been underestimated? Provocative findings from the Framingham Heart Study.
    Chobanian AV
    Circulation; 1996 Feb; 93(4):638-40. PubMed ID: 8640988
    [No Abstract]   [Full Text] [Related]  

  • 8. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
    Houston MC
    Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The HOT study].
    Klovning A; Sandvik H; Straand J
    Tidsskr Nor Laegeforen; 1999 Jan; 119(3):407. PubMed ID: 10074841
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hypertension in elderly patients with multiple morbidity].
    Slany J
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):4-6. PubMed ID: 15346545
    [No Abstract]   [Full Text] [Related]  

  • 12. Time to lower treatment BP targets for hypertension?
    Carlberg B
    Lancet; 2009 Aug; 374(9689):503-4. PubMed ID: 19683626
    [No Abstract]   [Full Text] [Related]  

  • 13. World Hypertension Day 2007.
    Jones DW; Hall JE
    Hypertension; 2007 May; 49(5):939-40. PubMed ID: 17420339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive treatment of the elderly. Does it help?].
    Nielsen WB; Jensen GB
    Ugeskr Laeger; 1998 Oct; 160(43):6195-7. PubMed ID: 9803866
    [No Abstract]   [Full Text] [Related]  

  • 15. Are guidelines effectively guiding antihypertensive therapy?
    Vasan RS; Kannel WB
    Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of different antihypertensive agents on the overall cardiovascular risk profile.
    Crepaldi G; Pessina AC; Rahn KH
    J Hypertens Suppl; 1993 Dec; 11(6):S37-9. PubMed ID: 8169382
    [No Abstract]   [Full Text] [Related]  

  • 17. First-line pharmacological treatment of hypertension.
    Burnier M; Waeber B; Brunner HR
    J Intern Med; 1992 Nov; 232(5):381-8. PubMed ID: 1453121
    [No Abstract]   [Full Text] [Related]  

  • 18. The hypertensive patient. Not just a number.
    Applegate WB
    Postgrad Med; 1992 Jul; 92(1):237-44. PubMed ID: 1614934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs for hypertension: should data precede conclusions?
    Myers MG
    CMAJ; 1990 Aug; 143(4):265-7. PubMed ID: 2200600
    [No Abstract]   [Full Text] [Related]  

  • 20. The South African Hypertension Guideline 2006 is evidence-based but not cost-effective.
    Gaziano TA
    S Afr Med J; 2006 Nov; 96(11):1170-3. PubMed ID: 17167701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.